^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

GNAQ mutation

i
Entrez ID:
Related biomarkers:
Phase 2
National Cancer Institute (NCI)
Active, not recruiting
Last update posted :
02/13/2024
Initiation :
02/25/2016
Primary completion :
09/01/2020
Completion :
12/31/2025
GNAQ • GNA11
|
GNAQ mutation • GNA11 mutation
|
Mekinist (trametinib)
Phase 2
GlaxoSmithKline
Withdrawn
Last update posted :
12/12/2017
Initiation :
11/01/2010
Primary completion :
08/01/2011
Completion :
05/01/2012
GNAQ • GNA11
|
GNAQ mutation • GNA11 mutation
|
Mekinist (trametinib)
Phase 2
National Cancer Institute (NCI)
Completed
Last update posted :
07/26/2017
Initiation :
06/01/2010
Primary completion :
05/01/2016
Completion :
05/01/2016
GNAQ • GNA11 • CYP1A2
|
GNAQ mutation
|
temozolomide • Koselugo (selumetinib) • dacarbazine